UNSPSC 51313800: Antihistamine or H1 blocker terfenadine/analogs and derivatives

Antihistamine or H1 blocker drugs made from a family of hexahydropyridines.

UNSPSC 51313800 Antihistamine or H1 blocker terfenadine/analogs and derivatives is a Class code that shows a significant mismatch between its nominal pharmaceutical scope and actual state and local procurement activity. The single recent opportunity posted under this code—Seminole County, Florida's IFB 60459723LAS—solicits naloxone and safe drug deactivation systems, which are emergency overdose-reversal medications and harm-reduction equipment, not antihistamines or terfenadine derivatives. The scope of work reflects public health and emergency preparedness procurement rather than antihistamine therapeutics, suggesting either a classification error in the source data or opportunistic tagging by the issuing body.

Seminole County, Florida posted the opportunity on June 30, 2026, with a response deadline of July 26, 2023 (an apparent date inconsistency in the source record). The procurement targets 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The IFB requires electronic submission through the county's e-Procurement Portal, unit pricing for each line item, drug-free workplace certification, E-Verify compliance, and standard insurance coverage (workers' compensation, general liability, professional liability). The initial contract term is two years with a one-year renewal option, and vendors must comply with FEMA requirements and federal environmental regulations. No explicit set-aside or disadvantaged-enterprise restrictions apply. The code shows no additional recent state or local opportunities, limiting visibility into broader activity patterns or geographic concentration across jurisdictions.